{"schema":"https://pith.science/schemas/pith-integrity/v1.json","pith_number":"2604.25064","arxiv_id":"2604.25064","integrity":{"available":true,"endpoint":"/pith/2604.25064/integrity.json","summary":{"critical":0,"advisory":1,"informational":0,"by_detector":{"doi_compliance":{"total":1,"critical":0,"advisory":1,"informational":0}}},"clean":false,"detectors_run":[{"name":"ai_meta_artifact","version":"1.0.0","status":"completed","ran_at":"2026-05-21T05:39:48.823836Z","findings_count":0},{"name":"doi_compliance","version":"1.0.0","status":"completed","ran_at":"2026-05-19T21:32:04.100332Z","findings_count":1}],"findings":[{"detector":"doi_compliance","finding_type":"recoverable_identifier","severity":"advisory","verdict_class":"incontrovertible","note":"DOI in the printed bibliography is fragmented by whitespace or line breaks. A longer candidate (10.1093/annonc/mdw413.Sawsan) was visible in the surrounding text but could not be confirmed against doi.org as printed.","detected_doi":"10.1093/annonc/mdw413.Sawsan","detected_arxiv_id":null,"ref_index":3,"audited_at":"2026-05-19T21:32:04.100332Z"}],"snapshot_sha256":"c7c312921063b7c5e4c1d3881d6bed57a9b26fe4e499659ef69ae9b5bac1ee6a"},"events":[{"event_id":3186,"event_type":"pith.integrity.v1","payload_sha256":"55226c12d8a9892ca05cf1d949e2e64564d438a78cd92038591682ca048f624e","signature_b64":"oTE7DdpzvdBY5IH/K3MwYzeh9u5diUZ8fD+e9v5r85HzVHQq/8tcHgLbGZVXtbqxt/kxUNxM1nDlce/syWqFCQ==","signing_key_id":"pith-v1-2026-05","created_at":"2026-05-19T21:32:23.165673+00:00","payload":{"note":"DOI in the printed bibliography is fragmented by whitespace or line breaks. A longer candidate (10.1093/annonc/mdw413.Sawsan) was visible in the surrounding text but could not be confirmed against doi.org as printed.","snippet":"doi: 10.1093/annonc/ mdw413. Sawsan Rashdan and David E Gerber. Going into battle: umbrella and basket clinical trials to accelerate the study of biomarker-based therapies.Annals of Translational Medicine, 4(24):529, dec","arxiv_id":"2604.25064","detector":"doi_compliance","evidence":{"ref_index":3,"verdict_class":"incontrovertible","resolved_title":null,"printed_excerpt":"doi: 10.1093/annonc/ mdw413. Sawsan Rashdan and David E Gerber. Going into battle: umbrella and basket clinical trials to accelerate the study of biomarker-based therapies.Annals of Translational Medicine, 4(24):529, dec","reconstructed_doi":"10.1093/annonc/mdw413.Sawsan"},"severity":"advisory","ref_index":3,"audited_at":"2026-05-19T21:32:04.100332Z","event_type":"pith.integrity.v1","detected_doi":"10.1093/annonc/mdw413.Sawsan","detector_url":"https://pith.science/pith-integrity-protocol#doi_compliance","external_url":null,"finding_type":"recoverable_identifier","evidence_hash":"f06504620b629932f625f90e09db014c2ae15e4ac40dc0386f17d04dc5de7cfd","paper_version":1,"verdict_class":"incontrovertible","resolved_title":null,"detector_version":"1.0.0","detected_arxiv_id":null}}],"endpoint_self":"/pith/2604.25064/integrity.json","protocol_url":"https://pith.science/pith-integrity-protocol"}